BioSpace News Archive

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Motif BioSciences Inc. (a wholly owned subsidiary) has entered into an amendment agreement with its lender Hercules Capital, Inc (NYSE:HTGC) (“Hercules”) in relation to the loan agreement as notified on 15 November 2017.

Hummingbird Bioscience, a systems-biology enabled biotech company focused on the discovery and development of novel cancer therapeutics, today announced James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D., have joined its Scientific Advisory Board.

In just 4 weeks’ time, SMi’s 21st Annual Superbugs & Superdrugs Conference will kick off in London, setting out to provide an international audience with key updates on the latest developments in combating antibiotic resistance, including the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.

Strategic Data Marketing and Northcoast Data Analytics announced the merger of their business operations to service the dental industry as a stronger, unified, one-stop source for all dental marketing, sales, and research data.

SkinBiotix®, which is already in human studies with its scientifically validated treatments for a variety of skin conditions, has raised £1.5 million from its original investor Seneca to further explore opportunities for its existing technology and support new areas of development.

Sirio Pharma Co. Ltd (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – today announces that it has been granted SC (production license) of sports nutrition food in China.

MycoTechnology has closed their Series C funding round co-led by S2G Ventures Fund II, L.P., Middleland MT Holdings, LLC, ADM Capital’s Cibus Fund, and TML-Invest S.à r.l. with participation from Tysons Ventures, Bunge Ventures Limited, Continental Grain Company, Eighteen94 Capital, LLC (Kellogg’s), and DNS-Hiitake LLC.

Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Arial Zeng Yi as Patient Derived Organoid (PDO) Consultant.

Projects will provide students with skills and resources to recognize unhealthy relationships

A panel of experts in pediatric heart disease shared the latest findings from their research at a large national conference hosted by the Cardiac Center at Children’s Hospital of Philadelphia in partnership with Children’s Hospital Los Angeles.